These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29731738)

  • 1. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of
    Mancarella C; Pasello M; Manara MC; Toracchio L; Sciandra EF; Picci P; Scotlandi K
    Front Endocrinol (Lausanne); 2018; 9():178. PubMed ID: 29731738
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Panebianco F; Kelly LM; Liu P; Zhong S; Dacic S; Wang X; Singhi AD; Dhir R; Chiosea SI; Kuan SF; Bhargava R; Dabbs D; Trivedi S; Gandhi M; Diaz R; Wald AI; Carty SE; Ferris RL; Lee AV; Nikiforova MN; Nikiforov YE
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2307-2312. PubMed ID: 28193878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy.
    Mancarella C; Pasello M; Ventura S; Grilli A; Calzolari L; Toracchio L; Lollini PL; Donati DM; Picci P; Ferrari S; Scotlandi K
    Clin Cancer Res; 2018 Aug; 24(15):3704-3716. PubMed ID: 29703820
    [No Abstract]   [Full Text] [Related]  

  • 4. A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
    Martins AS; Ordoñez JL; García-Sánchez A; Herrero D; Sevillano V; Osuna D; Mackintosh C; Caballero G; Otero AP; Poremba C; Madoz-Gúrpide J; de Alava E
    Cancer Res; 2008 Aug; 68(15):6260-70. PubMed ID: 18676850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.
    Neuzillet Y; Chapeaublanc E; Krucker C; De Koning L; Lebret T; Radvanyi F; Bernard-Pierrot I
    BMC Cancer; 2017 Sep; 17(1):636. PubMed ID: 28882129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
    Tian D; Mitchell I; Kreeger PK
    BMC Syst Biol; 2016 Feb; 10():15. PubMed ID: 26861122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
    Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
    J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the expression and role of IGF pathway biomarkers in human sarcomas.
    Lin F; Shen Z; Xu X; Hu BB; Meerani S; Tang LN; Zheng SE; Sun YJ; Min DL; Yao Y
    Int J Immunopathol Pharmacol; 2013; 26(1):169-77. PubMed ID: 23527719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
    Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
    PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor (IGF) 2 stimulates steroidogenesis and mitosis of bovine granulosa cells through the IGF1 receptor: role of follicle-stimulating hormone and IGF2 receptor.
    Spicer LJ; Aad PY
    Biol Reprod; 2007 Jul; 77(1):18-27. PubMed ID: 17360960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone.
    Peterse EF; Cleven AH; De Jong Y; Briaire-de Bruijn I; Fletcher JA; Danen EH; Cleton-Jansen AM; Bovée JV
    BMC Cancer; 2016 Jul; 16():475. PubMed ID: 27418340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.
    Tworkoski K; Raab-Traub N
    J Virol; 2015 Mar; 89(5):2590-602. PubMed ID: 25520502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
    Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
    Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin/Insulin-like growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies.
    Salisbury TB; Tomblin JK
    Front Endocrinol (Lausanne); 2015; 6():12. PubMed ID: 25699021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.
    Tian D; Kreeger PK
    BMC Syst Biol; 2014 Aug; 8():98. PubMed ID: 25115504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
    Li T; Wang J; Liu P; Chi J; Yan H; Lei L; Li Z; Yang B; Wang X
    Oncotarget; 2017 Jul; 8(29):47269-47283. PubMed ID: 28521298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
    Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis.
    Mancarella C; Caldoni G; Ribolsi I; Parra A; Manara MC; Mercurio AM; Morrione A; Scotlandi K
    Front Oncol; 2020; 10():994. PubMed ID: 32719743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression.
    Hartmann EM; Beà S; Navarro A; Trapp V; Campo E; Ott G; Rosenwald A
    Mod Pathol; 2012 Sep; 25(9):1227-35. PubMed ID: 22555177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.